December Newsmakers

FDA Names Flatiron Health Executive Amy Abernethy Deputy Commissioner (Forbes)
Features DCI alum Amy Abernethy, MD
Older Americans Are Flocking to Medical Marijuana (New York Times)
Features David Casarett, MD
Researchers develop DNA sequencing-based method to detect brain tumor (Xinhua)
Features Duke researchers
Emerging Technologies For Cancer Treatments (Euro Scientist)
Features The Preston Robert Tisch Brain Tumor Center
Duke Researchers Receive $1 Million to Study Link between Cancer & Environment (Triangle Business Journal)
Features Duke Cancer Institute
Precision BioSciences cleared to study novel cancer immunotherapy (WRAL Tech Wire)
Features Derek Jantz, PhD, and James Smith, PhD
WATCH: Case 1: BRAF-Mutated Metastatic Colorectal Cancer (Targeted Oncology)
Features Michael Morse, MD
Nephrectomy in the Era of Targeted Therapy: Takeaways from the CARMENA Trial (UroToday)
Written by Daniel George, MD
Treatment of Metastatic Non-Clear Cell RCC (Uro Today)
Written by Jason Zhu, MD
PROPHECY Trial: Circulating Tumor Cell as a Biomarker in mCRPC - Andrew Armstrong (Uro Today)
Features Andrew Armstrong, MD
Everolimus versus Sunitinib for Patients with Metastatic Non-clear Cell Renal Cell Carcinoma (ASPEN): a Multicentre, Open-label, Randomised Phase 2 Trial (Uro Today)
Features Andrew Armstrong, MD, and Susan Halabi, PhD
STARTAR Trial: Systemic Therapy in Salvage Setting for Prostate Cancer- Tian Zhang (Uro Today)
Features Tian Zhang, MD
PCI in Cancer; Beta-Blocker Prophylaxis; Stress Echo Predicts Cancer Deaths (MedPage Today)
Features Susan Dent, MD
Surgery Options for NSCLC & I-O Therapy in EGFR-Mutations (OncLive)
Features Thomas Stinchcombe, MD
WATCH: Dr. Strickler on the Importance of Molecular Markers in mCRC (OncLive)
Features John Strickler, MD
WATCH: Dr. George on the Use of Adjuvant Sunitinib in RCC (OncLive)
Features Daniel George, MD
WATCH: Recent developments for patients with stage III RCC (OncLive)
Features Daniel George, MD
WATCH: Dr. George on Sequencing in Renal Cell Carcinoma (OncLive)
Features Daniel George, MD
WATCH: DR. Secord on Personalized Treatment in Ovarian Cancer (OncLive)
Features Angeles Secord, MD
WATCH: Novel Biomarkers Panel at the Ruesch Center Annual Symposium 2018 (Ruesch Center)
Features John Strickler, MD
WATCH: Daniel George, MD, on the Latest Perspectives on Prostate Cancer (eight videos) (Wolters Kluwer)
Features Daniel George, MD
CRISPR-Cas9 Could Inhibit Anal Cancer Tumor Growth In vivo (Synthego)
Features Duke University Researchers
Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth (Alex's Lemonade Stand)
Features Kyle Walsh, PhD
Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants (Duke University School of Medicine)
Features Mitchell Horwitz, MD
Dr. William Eward Participated in the 12th Annual V Week for Cancer Research on ESPN (Duke Orthopaedic Surgery)
Features William Eward, MD, DVM
Nature vs. Nurture: Transforming Medicine with Gene Therapy (Duke Surgery)
Features Dawn Bowles, PhD, and Carmelo Milano, MD
LISTEN: The Cancer Distress Coach (Voices of Duke Health)
Features Sophia Smith, PhD, MSW
PAPERS
Novel cancer therapies and their association with diabetes. Journal of Molecular Endocrinology. February 2019. Afreen Idris Shariff, Sohail Syed, Rebecca A Shelby, Jeremy Force, Jeffrey Melson Clarke, David D’Alessio and Leonor Corsino.
TET2 Deficiency Sets the Stage for B-cell Lymphoma. Cancer Discovery. December 2018. Jennifer R. Shingleton and Sandeep S. Dave.
Phase I/II study of stem-cell transplantation using a single cord blood unit expanded ex vivo with nicotinamide. Journal of Clinical Oncology. Dec. 4, 2018. Mitchell E. Horwitz, Stephen Wease, Beth Blackwell, David Valcarcel, Francesco Frassoni, Jaap Jan Boelens, Stefan Nierkens, Madan Jagasia, John E. Wagner, Jurgen Kuball, Liang Piu Koh, Navneet S. Majhail, Patrick J. Stiff, Rabi Hanna, William Y.K. Hwang, Joanne Kurtzberg, Daniela Cilloni, Laurence S. Freedman, Pau Montesinos, and Guillermo Sanz.
Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women. Journal of Women’s Health. Nov. 27, 2018. Patricia G. Moorman, Nadine J. Barrett; Frances Wang, J. Anthony Alberg, Elisa V. Bandera, J.B. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, Linda E. Kelemen, Lauren C. Peres, Edwards S. Peters, A. G. Schwartz, Paul D. Terry, Sydnee Crankshaw,Sarah E. Abbott and Joellen M. Schildkraut.
Gender trends in gynecologic oncology authorship: Implications for the critical evaluation of gender distribution in academic rank and leadership positions. Gynecologic Oncology. Dec. 2018. Salinaro JR, Puechl AM, Havrilesky LJ; Davidson BA.